Long-Term Assets: The sum of all assets classified as non-current.
Vaxcyte, Inc. (PCVX) had Long-Term Assets of $1.38B for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-766.63M |
|
-- |
|
-- |
|
$923.67M |
|
$-923.67M |
|
$157.05M |
|
$-766.63M |
|
$-766.63M |
|
$-766.63M |
|
$-766.63M |
|
$-766.63M |
|
$-766.63M |
|
$-923.67M |
|
$-913.25M |
|
136.09M |
|
136.09M |
|
$-5.63 |
|
$-5.63 |
|
| Balance Sheet Financials | |
$1.63B |
|
$257.37M |
|
|
Long-Term Assets |
$1.38B |
$3.00B |
|
$205.75M |
|
-- |
|
$111.46M |
|
$317.21M |
|
$2.69B |
|
$2.69B |
|
$2.69B |
|
131.06M |
|
| Cash Flow Statement Financials | |
$-655.58M |
|
$437.35M |
|
$2.01M |
|
$389.19M |
|
$175.43M |
|
$-213.77M |
|
$138.84M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
7.91 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-669.29M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-28.55% |
|
-28.55% |
|
-25.53% |
|
-28.55% |
|
$20.49 |
|
$-4.92 |
|
$-4.82 |
|